Syschem (India) Limited (BOM:531173)

Market Cap	2.04B
Revenue (ttm)	4.75B
Net Income (ttm)	45.35M
Shares Out	43.51M
EPS (ttm)	0.88
PE Ratio	53.07
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	13,505
Average Volume	20,967
Open	50.46
Previous Close	49.47
Day's Range	48.00 - 50.46
52-Week Range	35.33 - 62.00
Beta	-0.99
RSI	35.75
Earnings Date	Feb 2, 2026

About Syschem (India)

Syschem (India) Limited engages in the production and sale of active pharmaceuticals ingredients (API), intermediates, bulk drugs, and specialty chemicals in India. Its APIs/intermediates include amoxycillin trihydrate, ampicillin trihydrate, cloxacillin sodium, dicloxacillin sodium, flucloxacillin sodium, cephalexin, and cefadroxil. The company also engages in the distillation of specialty solvents, such as methonel, acetonitrile, ethyl acetate, and THF; and contract manufacturing business. Syschem (India) Limited was incorporated in 1993 and ...

• Industry: Industrial Organic Chemicals
• Founded: 1993
• Employees: 115
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 531173

Financial Performance

In 2024, Syschem (India)'s revenue was 3.86 billion, an increase of 65.43% compared to the previous year's 2.33 billion. Earnings were 4.60 million, a decrease of -83.34%.